Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(19)31285-1
PubMed Identifier: 31327563
Publication URI: http://europepmc.org/abstract/MED/31327563
Type: Journal Article/Review
Volume: 394
Parent Publication: Lancet (London, England)
Issue: 10202
ISSN: 0140-6736